SCWorx Corp. (Nasdaq: WORX) announced today that it confirms previously disclosed plans to distribute COVID-19 Rapid Testing Units. Previously, the company announced receiving a committed purchase order from Rethink My Healthcare, a U.S.-based virtual healthcare network, for two million COVID-19 Rapid Testing Units, with provision for additional weekly orders of 2 million units for 23 weeks, valued at $35M per week.
Under the previously disclosed purchase order, SCWorx will supply Rethink My Healthcare with IgM/IgG Rapid Detection Kits. SCWorx continues to anticipate receiving the first 2 million rapid detection kits within approximately two weeks and looks forward to providing incremental updates as they become available.
Preparing Healthcare Facilities for Wildfire Air Quality Events
UW Health Set to Open Expansion at East Madison Hospital
Central Ohio Primary Care Physicians Falls Victim to Cyberattack
The Role of Biophilic Design in Healthcare Facilities
TriStar Centennial Medical Center Invests $90M in Women, Children's Hospital Expansions